Increased mortality with FLA compared with ADE chemotherapy in high-risk AML

Blood. 2006 Dec 1;108(12):3950-1; author reply 3951. doi: 10.1182/blood-2006-06-032680.
No abstract available

Publication types

  • Comment
  • Comparative Study
  • Letter

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage*
  • Cytarabine / administration & dosage
  • Daunorubicin / administration & dosage
  • Disease-Free Survival
  • Etoposide / administration & dosage
  • Female
  • Humans
  • Leukemia, Myeloid, Acute / drug therapy*
  • Leukemia, Myeloid, Acute / mortality*
  • Male
  • Middle Aged
  • Remission Induction
  • Retrospective Studies
  • Risk Factors
  • Survival Rate
  • Treatment Outcome

Substances

  • Antineoplastic Agents
  • Cytarabine
  • Etoposide
  • Daunorubicin

Supplementary concepts

  • DAV regimen